Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 3, 2016
Pharmacy Choice - Pharmacy News - May 3, 2016

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
5/3/16 - BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators
--BIOTRONIK, a leader in cardio- and endovascular medical technology, today announced Food and Drug Administration approval of Iperia ProMRI HF-T, a cardiac resynchronization defibrillator that provides heart failure patients with access to diagnostic magnetic resonance imaging scans. Iperia devices also have remote monitoring with daily automatic.
5/3/16 - FDA approves Nuplazid to treat hallucinations in Parkinsonâ??s disease
The FDA has approved Acadia's Nuplazid, the first drug approved to treat hallucinations and delusions experienced by some people with Parkinson's disease...
5/3/16 - RNK in Beta for FDA Cleared Telemedicine Stethoscope Software
RNK Products, Inc. is beta testing a simplified version of its FDA approved sSOIP telemedicine stethoscope software that enables the stethoscope stream to go over the video conferencing audio channel. This signal processing must be FDA cleared as "accessory" elements to the electronic stethoscope itself. If any of the stethoscope signal processing
5/3/16 - Synaptive Medical Receives FDA Clearance for Health Informatics Platform [Palestine Chronicle, The]
Synaptive Medical Inc., is pleased to announce the Food and Drug Administration clearance of ImageDrive Pro, an informatics platform designed to seamlessly integrate their existing BrightMatter technologies. The need for deeper interconnectivity and integration of our own systems and data platforms is essential as we look at introducing novel imagi
5/2/16 - Allergan Launches Generic Version Of CRESTOR
LONDON- Allergan plc confirmed it has received approval from the U.S. FDA on its Abbreviated New Drug Application for rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic version of AstraZeneca's CRESTOR tablets. Under the agreement with AstraZeneca on March 25, 2013, Allergan has launched its generic version of CRESTOR 67 days prior to Ju
5/2/16 - Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR® (rosuvastatin)
--Allergan plc, a leading global pharmaceutical company, today confirmed that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic version of AstraZeneca's CRESTOR ® tablets. Following receipt of the FDA approval, Allergan

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415